Acta Metallurgica Sinica

Previous Articles     Next Articles

Serum S100B protein and GFAP detection in neonates born to mothers with preeclampsia and its clinical significance.

SUN JingZHANG Xiao-Li.   

  1. Department of Pediatrics,Shanxi Medical University, Taiyuan 030001, China
  • Received:2014-04-30 Revised:2014-04-30 Online:2014-05-06 Published:2014-04-30

子痫前期母亲所生新生儿血清S100B蛋白和胶质纤维酸性蛋白检测及其临床意义

孙晶张小莉   

  1. 作者单位: 1.山西医科大学儿科医学系, 山西 太原 030001;2. 山西省儿童医院, 山西  太原  030032 (第二作者现工作于山西医学科学院 山西大医院)

Abstract:

Abstract: Objective To discuss the changes of S100B protein and GFAP levels and its relationship with 1 min Apgar scoring in the serum of neonates born to mothers with preeclampsia of different degrees. Methods From Oct.2012 to Mar.2013 in Chilren’s hospital of Shanxi province , 40 cases of newborns born to mothers with preeclampsia were divided into two groups: mild preeclampsia group (L group 20 cases);severe preeclampsia group (H group 20 cases);a healthy control group was established (N group 20 cases);newborns of three groups were taken specimen at the time of admission , dual- antibody sandwich enzyme-linked immunosorbent assay (ELISA) was used to detect the level of serum GFAP and S100B . In the first three days after admission cranial ultrasound was performed in each child. Results The difference among the L,H and N group was statistically significant (P2=17.20,P<0.05); S100B and GFAP levels in L and H group were positively correlated (γ= 0.658, P<0.05); S100B, GFAP levels in L and H group and neonatal 1min Apgar score were negatively correlated (γ$subScript$S100B$/subScript$=-0.482,γ$subScript$GFAP$/subScript$=-0.534,P<0.01). Conclusion The more serious eclampsia, the greater the possibility of brain damage, and the more serious the elevation of S100B and GFAP levels, and was negatively correlated with 1 min Apgar score, which indicates that the possibility of S100B protein and GFAP as a predictor of neonatal brain injury deserves further study.

Key words: Keywords: GFAP, S100B, preeclampsia, brain injury, neonate

摘要:

摘要: 目的 探讨S100B蛋白和胶质纤维酸性蛋白(GFAP)在不同程度子痫前期母亲所生新生儿血清中的变化、关系及与1 min Apgar评分的相关性,为早期预测新生儿脑损伤的可能性寻找依据。方法 选择2012年10月至2013年3月在山西省儿童医院子痫前期母亲所生新生儿40例,分为2组:子痫前期轻度组(L组)20例、子痫前期重度组(H组)20例,设立健康对照组(N组) 20例,三组新生儿均于入院时留取标本,采用双抗体夹心酶联免疫吸附法(ELISA)法检测血清GFAP和S1OOB浓度。另每例患儿均于入院后第3天行头颅超声检查。结果 L组、H组、N组之间血清S100B、GFAP浓度比较差异有统计学意义(P2=17.20,P<0.001);L组、H组S100B与GFAP浓度呈正相关(γ=0.658,P<0.05);L组、H组S100B、GFAP浓度与新生儿1 min Apgar评分均呈负相关(γ$subScript$S100B$/subScript$=-0.482, γ$subScript$GFAP$/subScript$=-0.534,P<0.01)。结论 母亲子痫前期程度越严重,新生儿脑损伤可能性越大,S100B和GFAP浓度升高越明显,与1 min Apgar评分呈负相关,说明S100B蛋白和GFAP做为预测新生儿脑损伤的可能性值得进一步研究。

关键词: 关键词:胶质纤维酸性蛋白, S100B, 子痫前期, 脑损伤, 新生儿